BriaCell Therapeutics Corp. CEO William Williams' 2023 pay jumps 50% to $1.2M

BriaCell Therapeutics Corp. reports 2023 executive compensation

By ExecPay News

Published: January 9, 2024

BriaCell Therapeutics Corp. reported fiscal year 2023 executive compensation information on January 9, 2024.
In 2023, four executives at BriaCell Therapeutics Corp. received on average a compensation package of $731K, a 67% increase compared to previous year.
Average pay of disclosed executives at BriaCell Therapeutics Corp.
William V. Williams, Chief Executive Officer, received $1.2M in total, which increased by 50% compared to 2022. 61% of Williams' compensation, or $737K, was in salary. Williams also received $49K in non-equity incentive plan, $307K in option awards, as well as $123K in stock awards.
Giuseppe Del Priore, Chief Medical Officer, received a compensation package of $949K, which increased by 128% compared to previous year. 49% of the compensation package, or $467K, was in salary.
Gadi Levin, Chief Financial Officer, earned $391K in 2023, a 53% increase compared to previous year.
Miguel A. Lopez-Lago, Chief Scientific Officer, received $368K in 2023, which increases by 37% compared to 2022.
BriaCell Therapeutics Corp.'s fiscal year ends on July 31.

Related executives

William Williams

BriaCell Therapeutics Corp.

Chief Executive Officer

Gadi Levin

BriaCell Therapeutics Corp.

Chief Financial Officer

Giuseppe Del Priore

BriaCell Therapeutics Corp.

Chief Medical Officer

Miguel Lopez-Lago

BriaCell Therapeutics Corp.

Chief Scientific Officer

You may also like

Source: SEC filing on January 9, 2024.